S3533 Indirect Impacts of COVID on Alcohol-Induced Liver Disease

Lee-Allen, Jannel; Manivannan, Ahila; Deneve, Daniel; May, Elizabeth; Ehrinpreis, Murray N.

doi:10.14309/01.ajg.0000716180.96961.d1

Am J Gastroenterol

2020

DOI: 10.14309/01.ajg.0000716180.96961.d1

|View full text |Cite

S3533 Indirect Impacts of COVID on Alcohol-Induced Liver Disease

Jannel Lee-Allen

Ahila Manivannan

Daniel Deneve

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Lactulose/rifaximin

2021

Reactions Weekly

View full text Add to dashboard Cite

Lactulose/rifaximinLack of drug effect: case report A 42-year-old man exhibited a lack of drug effect during treatment with lactulose and rifaximin for multifactorial encephalopathy. The man with history of alcohol induced liver cirrhosis (MELD-Na 13, Child Pugh-A), presented to emergency room due to one week history of worsening abdominal pain and distension. He used to live alone and reported loosing his job recently due to the pandemic that lead to an increase in his daily alcohol intake for the past month (increased to 12 beers daily from previous 6 beers). He last consumed alcohol 2 days prior to the presentation. Test showed negative result for COVID-19 infection. Further tests showed severe hyponatremia, acute kidney injury and tense ascites with worsening liver cirrhosis (MELD-Na 32, Child Pugh-C). Hyponatraemia resolved with unspecified appropriate treatment, and kidney function improved with midodrine, octreotide and albumin. Additionally, he received lactulose and rifaximin [routes and dosages not stated] for multifactorial encephalopathy (alcohol withdrawal, ICU delirium and hepatic encephalopathy); however, no improvement was noted and his hospitalisation was prolonged. Subsequently, he was shifted to ICU due to suspected aspiration versus hospital acquired pneumonia. He was then moved to comfort care and died on day 22 of to hospitalisation [immediate cause of death not stated].

show abstract

Lactulose/rifaximin

2021

Reactions Weekly

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

S3533 Indirect Impacts of COVID on Alcohol-Induced Liver Disease

Cited by 1 publication

References 2 publications

Lactulose/rifaximin

Lactulose/rifaximin

Contact Info

Product

Resources

About